tuneTypical Dose
15-30 g/day with food
Supplement
Chia Seeds
Salvia hispanica
Evidence TierCWADA NOT PROHIBITED
watchEffect Window
Start with 2-12 weeks for most practical outcomes.
check_circleCompliance
WADA NOT PROHIBITED
Overview
Clinical Summary
Chia seeds are a fiber- and ALA-rich whole food with modest evidence for triglyceride and blood-pressure improvement, but not dependable weight loss.
Chia seeds are best understood as a nutrient-dense whole-food adjunct rather than a targeted therapeutic supplement. The strongest current human signal is modest cardiometabolic benefit, especially triglyceride reduction in hypertriglyceridemia and small pooled effects on blood pressure. Weight-loss effects remain unconvincing, and the main practical safety issue is taking dry seeds without enough liquid.
Chia seeds provide viscous soluble fiber and ALA, which can slow carbohydrate absorption, increase satiety, and modestly improve triglycerides and blood pressure. Human effects are generally food-like and modest rather than pharmacologic.
Outcomes
What This Is Expected To Influence
Primary Outcomes
- Modest triglyceride and blood-pressure improvement in selected adults
- Useful fiber-rich food adjunct for glycemic and cardiometabolic support
Secondary Outcomes
- Not a dependable weight-loss intervention
- Generally safe when taken with adequate fluid
Safety
Contraindications and Interactions
Contraindications
- Pregnancy/lactation
- Severe liver or kidney disease
- Medication interactions
Side effects
- GI discomfort
- Drowsiness/sedation (agent-dependent)
- Headache
Interactions
- Drug absorption interactions
- Sedatives/CNS-active agents
- Anticoagulants
Avoid if
- Unknown source quality
- Unstable medical conditions
- Complex medication stack
Evidence
Study-level References
chia-seeds-SRC-001Systematic review and meta-regression analysis of randomized controlled trials.
Sourceopen_in_newFateh HL, Ahmed DH, Najafabadi MS, Moludi J. The impact of chia seeds on diabetes, blood pressure, lipid profile, and obesity indicators: Systematic review and meta-regression analysis of 14 randomized controlled trials. Prostaglandins Other Lipid Mediat. 2024;175:106907. doi:10.1016/j.prostaglandins.2024.106907. PMID:39299649.
Population: 835 participants across 14 randomized controlled trials.
Dose protocol: Meta-regression across 14 randomized chia-seed trials with variable doses and durations
Key findings: Modest improvements in triglycerides and blood pressure, with inconsistent effects on diabetes and obesity indicators.
Notes: Best quantitative overview of current cardiometabolic evidence.
Paper content
This meta-regression analysis pooled 14 RCTs with 835 participants to evaluate chia seed supplementation effects on cardiometabolic markers. Chia supplementation reduced triglycerides by 8.69 to 13.11 mg/dL (dose-dependent), LDL cholesterol by 4.77 mg/dL at higher doses, and systolic blood pressure by 2.78 mmHg at higher doses. The analysis suggests chia supplementation may offer modest beneficial effects on dyslipidemia, hypertension, and body weight, potentially mitigating cardiovascular disease risk. Effect sizes were modest and dose-dependent, supporting chia as a dietary adjunct rather than a primary therapeutic intervention.
chia-seeds-SRC-002Umbrella review synthesizing systematic reviews and meta-analyses of randomized controlled trials.
Sourceopen_in_newAl-Younis ZK, Al-Shawi SG, Kareem AK, et al. A Critical Review of the Health Benefits Associated with Chia Seeds (Salvia Hispanica L.). Plant Foods Hum Nutr. 2025;80(4):170. doi:10.1007/s11130-025-01401-z. PMID:41076614.
Population: Approximately 2500 participants across eight meta-analyses of RCTs.
Dose protocol: Critical review of mixed chia-seed supplementation protocols and safety considerations
Key findings: Broad health narrative remains stronger than the direct trial base. Highlights modest cardiometabolic potential, limited weight-loss support, and practical safety issues with dry seeds.
Notes: Useful for safety framing and for narrowing overstated marketing claims.
Paper content
This umbrella review synthesized eight meta-analyses involving approximately 2500 participants to evaluate chia seed supplementation for cardiometabolic health. Chia supplementation yielded statistically significant reductions in diastolic blood pressure (g = -0.550), total cholesterol (g = -0.300), LDL cholesterol (g = -0.300), triglycerides (g = -0.200), waist circumference (g = -0.289), and C-reactive protein (g = -0.165). Systolic blood pressure showed a smaller reduction (g = -0.119). Certainty of evidence ranged from moderate to low. The review supports modest cardiometabolic benefits from chia supplementation but not large therapeutic effects.
chia-seeds-SRC-003Systematic review and meta-regression analysis of randomized controlled trials.
Sourceopen_in_newFateh HL, Ahmed DH, Najafabadi MS, Moludi J. The impact of chia seeds on diabetes, blood pressure, lipid profile, and obesity indicators: Systematic review and meta-regression analysis of 14 randomized controlled trials. Prostaglandins Other Lipid Mediat. 2024;175:106907. doi:10.1016/j.prostaglandins.2024.106907. PMID:39299649.
Population: 835 participants across 14 randomized controlled trials.
Dose protocol: Chia seed supplementation at various doses across 14 RCTs (835 participants)
Key findings: Reduced triglycerides (8.69 to 13.11 mg/dL), LDL (4.77 mg/dL), and systolic blood pressure (2.78 mmHg) at higher doses.
Notes: Best modern meta-regression for chia cardiometabolic effects.
Paper content
This meta-regression analysis pooled 14 RCTs with 835 participants to evaluate chia seed supplementation effects on cardiometabolic markers. Chia supplementation reduced triglycerides by 8.69 to 13.11 mg/dL (dose-dependent), LDL cholesterol by 4.77 mg/dL at higher doses, and systolic blood pressure by 2.78 mmHg at higher doses. The analysis suggests chia supplementation may offer modest beneficial effects on dyslipidemia, hypertension, and body weight, potentially mitigating cardiovascular disease risk. Effect sizes were modest and dose-dependent, supporting chia as a dietary adjunct rather than a primary therapeutic intervention.
chia-seeds-SRC-004Umbrella review synthesizing systematic reviews and meta-analyses of randomized controlled trials.
Sourceopen_in_newAl-Younis ZK, Al-Shawi SG, Kareem AK, et al. A Critical Review of the Health Benefits Associated with Chia Seeds (Salvia Hispanica L.). Plant Foods Hum Nutr. 2025;80(4):170. doi:10.1007/s11130-025-01401-z. PMID:41076614.
Population: Approximately 2500 participants across eight meta-analyses of RCTs.
Dose protocol: Umbrella review of 8 meta-analyses (~2500 participants)
Key findings: Significant reductions in diastolic BP (g=-0.550), total cholesterol (g=-0.300), LDL (g=-0.300), triglycerides (g=-0.200), and CRP (g=-0.165).
Notes: Highest-level evidence synthesis available for chia seeds.
Paper content
This umbrella review synthesized eight meta-analyses involving approximately 2500 participants to evaluate chia seed supplementation for cardiometabolic health. Chia supplementation yielded statistically significant reductions in diastolic blood pressure (g = -0.550), total cholesterol (g = -0.300), LDL cholesterol (g = -0.300), triglycerides (g = -0.200), waist circumference (g = -0.289), and C-reactive protein (g = -0.165). Systolic blood pressure showed a smaller reduction (g = -0.119). Certainty of evidence ranged from moderate to low. The review supports modest cardiometabolic benefits from chia supplementation but not large therapeutic effects.
chia-seeds-SRC-005Randomized controlled trial with three parallel groups.
Sourceopen_in_newShahparvari MR, Nasrollahzadeh J. Effect of chia seeds or concentrated fish oil on cardiometabolic risk markers in subjects with hypertriglyceridaemia: a parallel clinical trial. J Hum Nutr Diet. 2024;37(6):1558-1570. doi:10.1111/jhn.13369. PMID:39360590.
Population: 66 adults with hypertriglyceridemia, 22 per group.
Dose protocol: 30 g/day chia seeds versus fish oil versus diet alone for 8 weeks
Key findings: Triglyceride reduction comparable to fish oil (145.2 mg/dL decrease). Greater diastolic BP reduction (8.4 mmHg) than comparators.
Notes: Direct head-to-head comparison with fish oil in hypertriglyceridemic adults.
Paper content
This 8-week three-arm RCT compared chia seeds (30 g/day) versus concentrated fish oil (1.8 g/day omega-3 PUFAs) versus low-calorie diet alone in 66 adults with hypertriglyceridemia. The chia group showed triglyceride reduction comparable to fish oil (145.2 versus 136.7 mg/dL decrease, P=0.001 versus control). Chia seeds produced a greater diastolic blood pressure reduction (8.4 mmHg) than either fish oil or diet alone. The study provides direct comparative evidence that chia seeds can produce clinically meaningful triglyceride and blood pressure reductions in adults with elevated lipids.